Stockreport

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results [Yahoo! Finance]

NovaBay Pharmaceuticals, Inc.  (NBY) 
NASDAQ:AMEX Investor Relations: novabay.com/investors
PDF Sales and marketing expenses for the quarter declined 27% reflecting digital marketing optimization Divestiture of skincare segment expected to bolster cash position [Read more]